KDR and hepatocellular carcinoma: These observations are consistent with mechanisms implicated in preclinical studies in murine HCC models, as well as data showing that VEGF/VEGFR2 blockade can inhibit Treg and MDSC accumulation tumors or blood in human cancers (52, 63, 95, 101).